Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure

Satoshi Honda(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Atsushi Okada(National Cerebral and Cardiovascular Center), Kengo Kusano(Northwestern University), Yasuo Sugano(keiyu Hospital), Toshiyuki Nagai(Hokkaido University), Satoshi Yasuda(Tohoku University)
International Journal of Cardiology
July 31, 2016
10.1016/j.ijcard.2016.07.236
Cited by 59

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753